Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes

The aim of our study was to analyse inherited thrombotic disorders that influence the long-term outcome of PTA. Methods. Diabetic patients with peripheral arterial disease (PAD) treated by PTA in our centre between 2008 and 2011 were included in the study. Patients were divided into unsuccessful PTA...

Full description

Saved in:
Bibliographic Details
Main Authors: Michal Dubský, Alexandra Jirkovská, Libuše Pagáčová, Robert Bém, Andrea Němcová, Vladimíra Fejfarová, Veronika Wosková, Edward B. Jude
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2015/369758
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549745076207616
author Michal Dubský
Alexandra Jirkovská
Libuše Pagáčová
Robert Bém
Andrea Němcová
Vladimíra Fejfarová
Veronika Wosková
Edward B. Jude
author_facet Michal Dubský
Alexandra Jirkovská
Libuše Pagáčová
Robert Bém
Andrea Němcová
Vladimíra Fejfarová
Veronika Wosková
Edward B. Jude
author_sort Michal Dubský
collection DOAJ
description The aim of our study was to analyse inherited thrombotic disorders that influence the long-term outcome of PTA. Methods. Diabetic patients with peripheral arterial disease (PAD) treated by PTA in our centre between 2008 and 2011 were included in the study. Patients were divided into unsuccessful PTA group (75 patients), successful PTA group (58 patients), and control group (65 patients, with diabetes but no PAD). Diagnosis of inherited thrombotic disorders included mutation in factor V (Leiden), factor II (prothrombin), and mutation in genes for methylenetetrahydrofolate reductase—MTHFR (C677T and A1298C). Results. The genotypic frequency of Leiden allele G1691A was significantly associated with a risk of unsuccessful PTA in comparison with successful PTA group and control group (OR 8.8 (1.1–70.6), p=0.041, and OR 9.8 (1.2–79.2), p=0.032, resp.). However, we only observed a trend for the association of the prothrombin allele G20210A and risk of PTA failure. The frequencies of alleles of MTHFR 677 or 1298 did not differ significantly among the groups. Conclusion. Our study showed higher frequency of heterozygous form of Leiden mutation in diabetic patients with unsuccessful outcome of PTA in comparison with patients with successful PTA and diabetic patients without PAD.
format Article
id doaj-art-c28904c653c34fce8bef025cc0477d7b
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-c28904c653c34fce8bef025cc0477d7b2025-02-03T06:08:48ZengWileyJournal of Diabetes Research2314-67452314-67532015-01-01201510.1155/2015/369758369758Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with DiabetesMichal Dubský0Alexandra Jirkovská1Libuše Pagáčová2Robert Bém3Andrea Němcová4Vladimíra Fejfarová5Veronika Wosková6Edward B. Jude7Diabetes Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech RepublicDiabetes Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech RepublicDiabetes Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech RepublicDiabetes Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech RepublicDiabetes Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech RepublicDiabetes Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech RepublicDiabetes Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech RepublicDiabetes Centre, Tameside Hospital NHS Foundation Trust and University of Manchester, Ashton-Under-Lyne OL6 9RW, UKThe aim of our study was to analyse inherited thrombotic disorders that influence the long-term outcome of PTA. Methods. Diabetic patients with peripheral arterial disease (PAD) treated by PTA in our centre between 2008 and 2011 were included in the study. Patients were divided into unsuccessful PTA group (75 patients), successful PTA group (58 patients), and control group (65 patients, with diabetes but no PAD). Diagnosis of inherited thrombotic disorders included mutation in factor V (Leiden), factor II (prothrombin), and mutation in genes for methylenetetrahydrofolate reductase—MTHFR (C677T and A1298C). Results. The genotypic frequency of Leiden allele G1691A was significantly associated with a risk of unsuccessful PTA in comparison with successful PTA group and control group (OR 8.8 (1.1–70.6), p=0.041, and OR 9.8 (1.2–79.2), p=0.032, resp.). However, we only observed a trend for the association of the prothrombin allele G20210A and risk of PTA failure. The frequencies of alleles of MTHFR 677 or 1298 did not differ significantly among the groups. Conclusion. Our study showed higher frequency of heterozygous form of Leiden mutation in diabetic patients with unsuccessful outcome of PTA in comparison with patients with successful PTA and diabetic patients without PAD.http://dx.doi.org/10.1155/2015/369758
spellingShingle Michal Dubský
Alexandra Jirkovská
Libuše Pagáčová
Robert Bém
Andrea Němcová
Vladimíra Fejfarová
Veronika Wosková
Edward B. Jude
Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes
Journal of Diabetes Research
title Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes
title_full Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes
title_fullStr Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes
title_full_unstemmed Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes
title_short Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes
title_sort impact of inherited prothrombotic disorders on the long term clinical outcome of percutaneous transluminal angioplasty in patients with diabetes
url http://dx.doi.org/10.1155/2015/369758
work_keys_str_mv AT michaldubsky impactofinheritedprothromboticdisordersonthelongtermclinicaloutcomeofpercutaneoustransluminalangioplastyinpatientswithdiabetes
AT alexandrajirkovska impactofinheritedprothromboticdisordersonthelongtermclinicaloutcomeofpercutaneoustransluminalangioplastyinpatientswithdiabetes
AT libusepagacova impactofinheritedprothromboticdisordersonthelongtermclinicaloutcomeofpercutaneoustransluminalangioplastyinpatientswithdiabetes
AT robertbem impactofinheritedprothromboticdisordersonthelongtermclinicaloutcomeofpercutaneoustransluminalangioplastyinpatientswithdiabetes
AT andreanemcova impactofinheritedprothromboticdisordersonthelongtermclinicaloutcomeofpercutaneoustransluminalangioplastyinpatientswithdiabetes
AT vladimirafejfarova impactofinheritedprothromboticdisordersonthelongtermclinicaloutcomeofpercutaneoustransluminalangioplastyinpatientswithdiabetes
AT veronikawoskova impactofinheritedprothromboticdisordersonthelongtermclinicaloutcomeofpercutaneoustransluminalangioplastyinpatientswithdiabetes
AT edwardbjude impactofinheritedprothromboticdisordersonthelongtermclinicaloutcomeofpercutaneoustransluminalangioplastyinpatientswithdiabetes